Gancaonin P

Gancaonin P

SCHEMBL1170933

CC(C)=CCc1c(O)cc2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 4/20 0.76
PDE5A O76074 1/20 0.72
AKT1 P31749 2/20 0.69
ABCG2 Q9UNQ0 2/20 0.68
PTPN1 P18031 5/20 0.64
AMY1A P0DUB6 2/20 0.64
PIM1 P11309 2/20 0.64
CD38 P28907 2/20 0.64
PDE4D Q08499 2/20 0.63
CYP19A1 P11511 6/20 0.62
FASN P49327 3/20 0.62
NUDT1 P36639 3/20 0.62
GAA P10253 3/20 0.62
SI P14410 3/20 0.62
AKR1B1 P15121 3/20 0.62
MGAM2 Q2M2H8 3/20 0.62
IDH1 O75874 2/20 0.62
PGAM1 P18669 2/20 0.62
SIRT2 Q8IXJ6 2/20 0.62
PTGS2 P35354 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26621024 0.91 MGAM (0.73) MGAMPDE5AAKT1ABCG2PTPN1
SCHEMBL24075660 0.91 MGAM (0.80) MGAMPDE5AAKT1ABCG2PTPN1
SCHEMBL29833229 0.91 MGAM (0.80) MGAMPDE5AAKT1ABCG2PTPN1
SCHEMBL6822263 0.91 ABCG2 (0.84) MGAMPDE5AAKT1ABCG2PTPN1
SCHEMBL6822261 0.91 ABCG2 (0.84) MGAMPDE5AAKT1ABCG2PTPN1
Licoflavonol SCHEMBL29392785 0.90 ABCG2 (0.82) MGAMPDE5AAKT1ABCG2PTPN1
Licoflavonol SCHEMBL8050093 0.90 ABCG2 (0.82) MGAMPDE5AAKT1ABCG2PTPN1
SCHEMBL26621022 0.89 MGAM (0.72) MGAMPDE5AAKT1ABCG2PTPN1
SCHEMBL30020726 0.88 PTPN1 (0.67) MGAMPDE5AABCG2PTPN1PDE4D
SCHEMBL30766286 0.88 PTPN1 (0.83) MGAMPDE5AAKT1PTPN1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795127-B2 Processes for the preparation of ortho-allylated hydroxy aryl compounds MCMASTER UNIVERSITY (CA) 2023-10-24 US disclosed
US-20230113567-A1 PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS MCMASTER UNIVERSITY (CA) 2023-04-13 US disclosed
US-20210380513-A1 PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS MCMASTER UNIVERSITY (CA) 2021-12-09 US disclosed
WO-2021237371-A1 PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS MCMASTER UNIVERSITY (CA) 2021-12-02 WO disclosed
WO-2021125342-A1 COMPOSITION FOR SUPPRESSING OBESITY 株式会社ダイセル 2021-06-24 WO disclosed
US-7888388-B2 Peroxisome proliferator activated receptor ligand and process for producing the same KANEKA CORPORATION (JP) 2011-02-15 US disclosed
US-7524975-B2 Peroxisome proliferator activated receptor ligand and process for producing the same KANEKA CORPORATION (JP) 2009-04-28 US disclosed
US-20090036519-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME KANEKA CORPORATION (JP) 2009-02-05 US disclosed
CN-1599602-A Peroxisome proliferator activated receptor ligands and process for producing the same KANEGAFUCHI CHEMICAL IND (JP) 2005-03-23 CN disclosed
US-20050014819-A1 Peroxisome proliferator activated receptor ligands and process for producing the same KANEKA CORPORATION (JP) 2005-01-20 US disclosed
EP-1440688-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGANDS AND PROCESS FOR PRODUCING THE SAME KANEKA CORPORATION (JP) 2004-07-28 EP disclosed
US-6737439-B2 ACTIVE CANCER CHEMOPREVENTATIVE AND TREATING AGENTS IN MAMMALS, INCLUDING HUMANS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2004-05-18 US disclosed
US-20030125377-A1 Aromatase inhibitors from Broussonetia papyrifera BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS THE 2003-07-03 US disclosed
WO-2003013554-A2 AROMATASE INHIBITORS FROM BROUSSONETIA PAPYRIFERA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2003-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113567-A1 PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS ADH1A, ADH1C, AHR MGAM 3381/4885PDE5A 4858/4885AKT1 972/4885
US-20030125377-A1 Aromatase inhibitors from Broussonetia papyrifera CYP19A1, HSD17B11, CYP17A1 MGAM 1782/4885PDE5A 414/4885AKT1 956/4885
US-20210380513-A1 PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS ADH1A, ADH1C, AHR MGAM 3381/4885PDE5A 4858/4885AKT1 972/4885
US-20090036519-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME PPARG, PPARA, PPARD MGAM 1182/4885PDE5A 3857/4885AKT1 1023/4885
US-11795127-B2 Processes for the preparation of ortho-allylated hydroxy aryl compounds ADH1A, ADH1C, AHR MGAM 3381/4885PDE5A 4858/4885AKT1 972/4885
US-20050014819-A1 Peroxisome proliferator activated receptor ligands and process for producing the same PPARG, PPARA, PPARD MGAM 1180/4885PDE5A 3588/4885AKT1 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.